Trial intelligence / Profile preview

Long-term follow-up of stromal vascular fraction-seeded calcium phosphate scaffold in maxillary sinus floor elevation

NL-OMON54923Recruiting

Sponsor
Vrije University Medical Center
Start
Aug 2021
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Open-label trial of autologous adipose stromal vascular fraction in Maxillary hypoplasia and edentulism (2 arms), sponsored by Vrije University Medical Center. Primary endpoints: Radiological changes, Clinical tissue changes and 2 more. Started Aug 2021; status: recruiting.

02

Drugs

autologous adipose stromal vascular fraction
03

Conditions

Maxillary hypoplasiaedentulism

Beyond the preview

Go deeper on NL-OMON54923.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON54923.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call